Shareholders to Vote on 3 Million Share Increase for Equity Incentive Plan, Potential 6.24% Dilution

summarizeSummary

Acadia Healthcare is seeking shareholder approval to increase its equity incentive plan by 3 million shares, which could result in over 6% potential dilution if fully utilized, alongside routine governance matters for its annual meeting.

check_boxKey Events

• Equity Incentive Plan Amendment Proposed

  Shareholders will vote on a proposal to increase the aggregate number of shares available for issuance under the Amended and Restated Incentive Compensation Plan by 3,000,000 shares. This increase, combined with existing available shares, would bring the total potential shares for awards to 5,741,999, representing approximately 6.24% of current outstanding common stock if fully issued.

• Director Nominees for Election

  Three Class III directors are nominated for re-election: Michael J. Fucci, Patrice A. Harris, M.D., M.A., and Daniel J. Cancelmi. Wade D. Miquelon, a current Class III director, has not been nominated for re-election. Daniel J. Cancelmi's appointment to the Board was previously announced on March 12, 2026, and the board size will decrease from 11 to 10 effective May 6, 2026.

• Advisory Vote on Executive Compensation

  A non-binding advisory vote will be held on the compensation of the named executive officers. The company noted that 2025 executive compensation payouts were below target due to financial performance, reflecting a pay-for-performance alignment.

• Auditor Ratification

  Shareholders are asked to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

auto_awesomeAnalysis

Acadia Healthcare has filed its definitive proxy statement for the upcoming annual meeting, outlining key proposals for shareholder vote. The most significant proposal is the request to amend the company's incentive compensation plan to increase the aggregate number of shares available for issuance by 3,000,000. If all shares currently available and those requested were issued, this would represent a potential dilution of approximately 6.24% of the current outstanding common stock. While equity incentive plans are common, this level of potential dilution is notable. The company also highlights that executive compensation payouts for 2025 were below target due to financial underperformance, demonstrating alignment with shareholder interests. Other proposals include the election of directors and the ratification of the independent auditor.